DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
DDP-225 is an investigational drug.
There have been 35 clinical trials for DDP-225. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2011.
The most common disease conditions in clinical trials are Carcinoma, Nasopharyngeal Neoplasms, and Esophageal Neoplasms. The leading clinical trial sponsors are Sun Yat-sen University, Fudan University, and Peking University.
Recent Clinical Trials for DDP-225
|Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study||Sun Yat-sen University||Phase 1|
|Drugs Brain and Behavior (DDP)||University of Chicago||Early Phase 1|
|Efficacy and Safety of ddEC-ddP for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer||Second Affiliated Hospital, School of Medicine, Zhejiang University||Phase 2/Phase 3|